Ranbaxy, Virchow Launch Bonista Generic In India
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories and Virchow Biotech have launched a generic version of Bonista (teriparatide) injectable for treating osteoporosis. The drug was developed in part with aid from India's Department of Science and Technology. The treatment is based on the recombinant human parathyroid hormone. (Click here for more